CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
78.15
+1.46 (1.90%)
At close: Oct 31, 2025, 4:00 PM EDT
78.24
+0.09 (0.12%)
After-hours: Oct 31, 2025, 7:59 PM EDT
CVS Health Revenue
CVS Health had revenue of $102.24B in the quarter ending September 30, 2025, with 7.76% growth. This brings the company's revenue in the last twelve months to $391.69B, up 6.66% year-over-year. In the year 2024, CVS Health had annual revenue of $370.66B with 3.93% growth.
Revenue (ttm)
$391.69B
Revenue Growth
+6.66%
P/S Ratio
0.25
Revenue / Employee
$1,305,633
Employees
300,000
Market Cap
99.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 370.66B | 14.03B | 3.93% |
| Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
| Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
| Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
| Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
CVS News
- 2 days ago - CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity - PRNewsWire
- 3 days ago - My Top 10 High-Yield Picks For November 2025: One Yields 9%+ - Seeking Alpha
- 4 days ago - Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size - WSJ
- 4 days ago - CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High - Benzinga
- 4 days ago - CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings - Market Watch
- 4 days ago - CVS Posts Loss on Write-Down, Boosts Guidance - WSJ
- 4 days ago - CVS Reports Big Loss On Devalued Oak Street Clinics But Aetna Costs Are Stable - Forbes